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Qualitative studyObjective: Adverse events which result from medication errors are considered to be one of the most fre-
quently encountered patient safety issues in clinical settings. We undertook a qualitative investigation to
identify and explore factors relating to medication error in an adult oncology department in Saudi Arabia
from the perspective of healthcare professionals.
Methods: This was a qualitative study conducted in an adult oncology department in Saudi Arabia. After
obtaining required ethical approvals and written consents from the participants, semi-structured inter-
views and focus group discussions were carried out for data collection. A stratified purposive sampling
strategy was used to recruit medical doctors, pharmacists, and nurses. NVivo Pro version 11 was used
for data analyses. Inductive thematic analysis was adopted in the primary coding of data while secondary
coding of data was carried out deductively applying the Hospital Survey of Patient Safety Culture
(HSOPSC) framework.
Result: The total number of participants were 38. Majority of the participants were nurses (n = 24),
females (n = 30), and not of Saudi nationality (n = 31) with an average age of 36 years old. Causes of med-
ication errors were categorized into 6 themes. These causes were related teamwork across units, staffing,
handover of medication related information, accepted behavioural norms, frequency of events reported,
and non-punitive response to error.
Conclusion: There were numerous causes for medication errors in the adult oncology department. This
means substantive improvement in medication safety is likely to require multiple, inter-relating, com-
plex interventions. More research should be conducted to examine context-specific interventions that
may have the potential to improve medication safety in this and similar departments.
 2018 The Authors. Production and hosting by Elsevier B.V. on behalf of King Saud University. This is an
open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Patient safety refers to the prevention of harm to patients in
hospitals and other healthcare organisations by preventing, reduc-
ing, reporting and investigating adverse events that frequently leadto adverse healthcare outcomes (Mitchell, 2008). Adverse events
which are resulted from medication errors are considered to be
one of the most frequently encountered patient safety issues in
clinical settings (World Health Organization, 2016). Medication
error is, in turn, defined as any avoidable misuse of medications
that could result in patient harm (Polnariev, 2014).
The existing literature indicates that causes of medication
errors differ between countries. For example, a study conducted
in an oncology setting in France showed that 91% of errors were
related to prescriptions, followed by dispensing errors (8%) and
administration errors (1%) (Ranchon et al., 2011). On the other
hand, another study conducted in similar setting in the United
States showed that administration errors represented 41% of all
medication errors, followed by dispensing errors (38%), then writ-
ing and transcribing errors (21%) (Ford et al., 2006). Importantly,
the causes of medication errors may differ according to clinicalrtment
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For example, Kane-Gill et al. found that staff inexperience, illegi-
ble/unclear handwriting, and distractions were the key factors con-
tributing to medication errors in an Intensive Care Unit (ICU). In
contrast, workload, insufficient staffing, and lack of experience
contributed to medication errors in the General Care Unit (GCU)
of the same hospital (Kane-Gill et al., 2010). This suggests the need
to investigate causes of medication errors in specific clinical con-
texts in different countries to inform delivery of care.
Oncology care is a complex clinical context, treating patients
with life-threatening illness utilising toxic therapies. Cancer treat-
ment requires staff to follow complex treatment regimens, such as
chemotherapy, that require meticulous coordination of care and
expertise (Cheng et al., 2012; Neuss et al., 2013). Patients receive
multiple drugs that are administered in repetitive cycles depend-
ing on the stage and type of cancer. Indeed, chemotherapy admin-
istration is considered one of the most risky and challenging
treatments in medicine. ’A range of studies conducted in France,
Canada, United States, and Sweden identified missed doses and
failure to deliver results on laboratory tests required to start treat-
ment as common chemotherapy administration errors (Ranchon
et al., 2011; White et al., 2014; Chera et al., 2015; Fyhr et al.,
2017). In the Arab countries context, literature revealed a single
study which was conducted in Egypt and identified that undeter-
mined cancer staging in the treatment plan (68%) and dose errors
(66%) were the common causes of chemotherapy administration
errors (Barakat et al., 2016).
Due to the dearth of the studies conducted in the Arabic con-
text, we undertook a qualitative investigation to identify and
explore factors relating to medication error in an adult oncology
department in Saudi Arabia as the basis for designing an interven-
tion to reduce medication errors in this complex healthcare setting
(Craig et al., 2008). The research was informed by our previous
quantitative work to understand staff perceptions of patient safety
culture (Alharbi et al., 2018).2. Methods
2.1. Study setting and design
This study was conducted in the adult oncology department of a
public hospital in Saudi Arabia.
As medication errors are likely to be perceived differently by
different healthcare professionals, we adopted a social construc-
tivism paradigm (Hays and Singh, 2011). We used face-to-face,
semi-structured interviews to gain insight into healthcare profes-
sionals’ personal views and experiences related to medication
errors confidentially. We then conducted focus group discussions
to provide insight into participants’ shared perceptions of the
causes of medication errors (Savin-Baden and Major, 2013). The
interview and discussion topic guides were informed by findings
of our previous study (Alharbi et al., 2018) and other relevant liter-
ature (Khoja et al., 2011; Almutary and Lewis, 2012; Aljadhey et al.,
2014).2.2. Ethical considerations
Ethical approval was obtained from the institutional review
board, the medical director of the comprehensive cancer centre,
and the chair of the adult oncology department. Prior to starting
the interview and focus group discussion, potential participants
were provided with an information sheet including information
about the voluntary nature of this study and their right to with-
draw at any time. Written informed consent was obtained from
each participant. All data were professionally transcribed, storedPlease cite this article in press as: Alharbi, W., et al. Exploring healthcare profes
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ity and anonymity.
2.3. Sampling and recruitment
After obtaining the required ethics approval, an explanatory
email was sent to the medical director and the heads of doctors,
pharmacists, and nurses within the adult oncology department,
inviting them to take part in the study. A stratified purposive sam-
pling strategy was used to recruit medical doctors, pharmacists,
and nurses (Hays and Singh, 2011). These groups are involved in
prescription and administration of medication in this department.
The first author (WH) approached individuals to request their par-
ticipation in the study so to ensure participant confidentiality and
to facilitate openness. The time and place of interviews were cho-
sen on the basis of participant preference with consideration of the
Saudi Arabian culture (e.g. interviewing female participants while
doors kept open).
2.4. Data generation
The interview guide included questions about causes of
medication errors, causes of non-reporting of medication errors,
inter-professional communication related to medication errors,
suggestions for improving inter-professional communication,
teamwork across units, management support of patient safety,
and non-punitive response to error. Before finalising the interview
guide, three pilot interviews were conducted (one doctor, one
pharmacist, and one nurse). Questions related to the management
support of patient safety (e.g., in what ways do management not
support a safety culture?) were removed on the basis of feedback
from the pilot participants, who believed these questions were
too sensitive in general. Both the individual interviews and focus
group discussion were conducted in English by the first author
(WH) between August and September 2017. Data collection ended
when no new themes were identified in the data set (Hays and
Singh, 2011). The average length of an interview was approxi-
mately 20 min and 45 min for focus group discussions.
2.5. Data coding and analysis
All transcripts were anonymised before entering them into
qualitative data analysis software (NVivo Pro version 11) to facili-
tate the coding and analysing the data. Analysis was led by the first
author (WH) who read each transcript several times to become
familiar with data set. Coding was done through primary and sec-
ondary phases, each involving discussion and review of a sub-set of
transcripts by other members of the research team (JC and ZM).
Primary codes were inductively extracted based on the keywords
of the participants’ expressions. Upon completion of primary cod-
ing, codes with similar meaning were unified and the codes were
organised into sub-themes. Secondary coding was carried out
using the finalised codes across the transcripts. Thereafter (deduc-
tively), sub-themes were renamed and grouped, applying the
Hospital Survey of Patient Safety Culture (HSOPSC) framework
(Sorra and Dyer, 2010). All authors approved the final themes
and sub-themes generated from the data (Table 1).3. Results
3.1. Participant characteristics
Forty-one healthcare professionals were consented to take part
in this study. Three of the 41 withdrew from the study before inter-
view. Of the 38 remaining participants, 24 were nurses, seven weresionals’ perceptions of medication errors in an adult oncology department
s://doi.org/10.1016/j.jsps.2018.10.001
Table 1
An example of the coding process.
Text Code Sub-theme Theme
‘‘When one nurse is working for the six patients, or eight patient, or ten patients,
how can we improve the quality, it is not possible. The errors are going to
happen” (Medical Doctor1, Focus group 1)
Working for many patients Workload Staffing
Table 2
Participant demographics (n = 38).
Profession Gender Nationality Average age
Male Female Saudi Non-Saudi
Doctors 7 0 1 6 43
Pharmacists 1 6 6 1 31
Nurses 0 24 0 24 35
W. Alharbi et al. / Saudi Pharmaceutical Journal xxx (2018) xxx–xxx 3doctors, and seven were pharmacists. The majority of participants
were female (78.9%). Most participants were not of Saudi national-
ity (81.4%). The overall average participants’ age was 36 years old
(Table 2).3.2. Main themes
Participants’ perception on causes of medication errors were
categorized in six broad themes (Table 3). These themes are team-
work across units, staffing, handover of medication related infor-
mation, accepted behavioural norms, frequency of events
reported, and non-punitive response to error. The themes and
sub-themes are discussed in more details below.3.2.1. Teamwork across units
The majority of participants indicated that there was miscom-
munication between healthcare professionals across the different
units. This miscommunication seemed to be the result of two fac-
tors: underestimation of others’ professional roles, and gender
discrimination.3.2.1.1. Underestimation of other professions’ roles. Participants’
responses indicated that doctors monopolised the clinical
decision-making process and did not accept being questioned by
other healthcare professionals: ‘‘Doctors usually say do not question
us because we are the physicians. That’s the problem” (Nurse, Inter-
view 5). This was reinforced by the belief that the majority of doc-
tors viewed the role of other healthcare professionals as bound to
the doctor’s plans and orders: ‘‘doctors believe they are over the
pharmacists and nurses because of their responsibilities as doctorsTable 3
Causes of medication errors themes.
Themes Sub-theme








2. Look-alike and sound-alike medication
Accepted behavioural norms 1. Normalizing errors and near misses
2. Fear of shame
Frequency of event reported 1. Consequences of reporting
2. Feedback and communication about
error
Non-punitive response to error –
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believe this causes the medication error” (Pharmacist, Interview 3).
3.2.1.2. Gender discrimination. Female participants from all three
professional groups felt they worked in a culture where males
were viewed as superior to females. This was interpreted as gender
discrimination that limited their ability to communicate with male
team members: ‘‘If you are a female and doctor is a male, he doesn’t
accept your opinion even if you are a pharmacist. But when our male
supervisor calls him and explains the same thing to him, he is thinking
about this and he may change his mind” (Pharmacist, Interview 2).
3.2.2. Staffing
Participants stated that issues related to staffing such as work-
load and lack of experience increased the potential for medication
error occurrence.
3.2.2.1. Workload. The majority of participants claimed that one
major contributory factor for adverse events in general, and med-
ication errors in particular, was staff overload from working long
hours, resulting fatigue, which in turn increases the risk of adverse
events: ‘‘The doctors are working sixty hours per week and sometimes
you have an extra duty and sometimes you have an extra work” (Med-
ical Doctor 3, Focus Group 1). A second contributing factor for staff
overload was the imbalance between the number of available
healthcare professionals and admitted patients: ‘‘When one nurse
is working for six patients, or eight patients, or ten patients, how
can we improve the quality of care?” (Medical Doctor 1, Focus Group
1). Linked to this was the multiple tasks expected of staff. For
example: ‘‘. . .you have to talk to staff from other services, we have
to call the social worker, we have to call the pharmacy, we have to call
the physician and to call the spiritual services, so it is hard for us. The
load is heavy” (Nurse, Interview 13). The pace of working was also
felt to increase the risk of mistakes being made during healthcare
delivery: ‘‘sometimes nurses are in a hurry to give the medicine, so
they are not checking properly the medication effects like the right
drug, the right amount, and the right dosage we give the patient”
(Nurse 3, Focus Group 1).
3.2.2.2. Lack of experience. Medication errors were perceived to
occur frequently in the department because it is part of a teaching
hospital that enrols trainee doctors who do not have adequate pro-
fessional supervision: ‘‘Medication errors come from the residents,
yeah, residents for sure” (Pharmacist 1, Focus Group 1). Moreover,
due to the lack of effective training on local systems, new staff
who are not familiar with the medication management system in
this department may increase the risk of medication errorsionals’ perceptions of medication errors in an adult oncology department
s://doi.org/10.1016/j.jsps.2018.10.001
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department” (Nurse, Interview 6).
3.2.3. Handover of medication related information
The majority of participants mentioned that medication errors
happen during handing over of medication related information
between healthcare professionals due to issues related to hand-
writing, and look-alike and sound-alike medications.
3.2.3.1. Illegible handwriting. Most nurses mentioned that doctors’
illegible handwriting frequently contributes to mistakes occurring
during medications and prescriptions, and hinders the flow of staff
communication: ‘‘The handwriting of the physician. Sometimes it is
not clear, so this one is another cause of the medication error” (Nurse,
Interview 5). Similarly, some participants from the pharmacy
department indicated that in cases of encountering unclear pre-
scriptions, even some nursing staff, when contacted, did not have
any idea about the prescribed medication: ‘‘the doctor don’t write
the prescription very clear and the nurse don‘t has any idea about
the medication that the doctor prescribed” (Pharmacist, Interview 2).
In addition, one of the nurses stated that ‘‘we are losing time for
the communication because of the doctor’s handwriting” (Nurse, Inter-
view 1). Prescribing and administering processes relied on manual
processes as there were no electronic prescribing systems available
to the staff. Therefore, unclear handwriting could contribute to
delay in the provision of required medication in addition to errors
in medication administration.
3.2.3.2. Look-alike and sound-alike medication. Medications with
similar appearance and names contributed to medication errors:
‘‘LASA medication. LASA means look-alike and sound-alike medication.
That’s a very big cause for medication error” (Nurse, Interview 11).
Another medical doctor stated that ‘‘We have an issue with LASA
especially during verbal orders” (Medical doctor, Interview 1).
3.2.4. Accepted behavioural norms
Participants mentioned that some accepted behavioural norms,
such as normalising errors and near misses, and fear of shame, can
play role in the occurrence of medication errors.
3.2.4.1. Normalising errors and near misses. Participants perceived
adverse events as a normal part of medical practice. For example,
one medical doctor said that: ‘‘Medication errors usually happen dur-
ing practical medicine because there is a communication between
healthcare professionals, so this is normal” (Medical Doctor, Interview
3). In addition, near misses were less likely to be reported when
healthcare professionals believe that if there is no perceivable
patient harm, there is no need to report it: ‘‘they didn’t report it
because it didn’t reach and harm the patient, so they just never mind”
(Nurse, Interview 14).
3.2.4.2. Fear of shame. The data suggested that staff – particularly
nursing staff - hesitated to ask for clarification of unclear issues
related to patient safety as to do so could negatively affect their
reputation: ‘‘We are shy to ask sometimes if we didn’t understand
the order because we think that doctors will say oh! You do not know
how to read or understand” (Nurse, Interview 7). Importantly, this
reluctance to check was not limited to nurses: ‘‘most of our physi-
cians don’t say I don’t know, so they feel a shame that if he can contact
or consult with other specialty to correct or just assure that prescribed
medication is right” (Medical Doctor, Interview 4).
3.2.5. Frequency of events reported
The study participants were reluctant to report medication
errors for three reasons: adverse personal consequences, burden
of reporting, and the lack of feedback after reporting.Please cite this article in press as: Alharbi, W., et al. Exploring healthcare profes
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their mistakes would be held against them and alienate colleagues:
‘‘Because it makes enemies, really, so I don’t like to report very simple
things. No, I don’t like it but a big error I will report” (Pharmacist,
Interview 2). Another participant remarked that: ‘‘. . .it is a reward
if I like you, it is a punishment if I am angry with you, and so they for-
get this is about the patient” (Clinical Pharmacist, Interview 4). More-
over, some healthcare professionals perceived reporting incidents
as an extra task that required a lot of time and effort: ‘‘Because
reporting errors takes time, so they don’t report any medical or med-
ication error” (Nurse, Interview 12).
3.2.5.2. Feedback & communication about error. Some participants
believed that feedback and communication about errors played a
vital role in encouraging healthcare professionals to report adverse
events: ‘‘The feedback about errors is important because the error
happened and report is done, what is next?” (Medical Doctor 3, Focus
Group 1). However, participants complained about the lack of feed-
back mechanism after reporting errors: ‘‘We report the medication
error but we do not get any feedback” (Pharmacist 1, Focus Group
1). In addition, some participants indicated that it would be point-
less to report incidents if it would not help in informing improve-
ment ‘‘. . .better to avoid the problem, just keep quiet and sometimes
we are accepting that error because if we will report it, they will not
take any action” (Nurse 1, Focus Group 2).
3.2.6. Non-punitive response to error
Participants indicated that there was a culture of uncertainty
within the department that made staff hesitant to report errors.
Loss of trust between frontline staff and their supervisors was a
crucial factor hindering the reporting of errors: ‘‘Another reason
for not reporting errors is that nurses are afraid because if they commit
mistakes, they are not sure maybe their supervisor will blame them,
and at worst they will terminate the nurse” (Nurse, Interview 5).
There was a fear of punishment on discovery of errors: ‘‘Number
one, the fear – fear to be discovered that you did this mistake then
you will get a lot of consequences” (Nurse 2, Focus Group 1). Specific
consequences mentioned included poor performance evaluation as
a result of reporting an error, and potential litigation: ‘‘Sometimes
they are taking this issue to the high supervisors and committee,
maybe it’s going to the court and there is no support from the hospital”
(Nurse 2, Focus Group 2).4. Discussion
To our knowledge, this is the first qualitative study in Saudi Ara-
bia to explore contributing factors to medication errors in an adult
oncology department and one of the first studies to look at this
issue from the perspectives of a range of healthcare professionals
(doctors, pharmacists, and nurses).
Our findings suggest that teamwork between healthcare profes-
sionals is one of the main causes of medication errors in the
department. Participants of this study perceived that doctors
believe that they are the only decision makers in the department,
and that others, particularly females, do not have the right to ques-
tion them regardless of seniority and experience level. This per-
ceived superiority negatively affected the working relationships
and communication between team members, particularly in
departments where most staff members were female. Additionally,
people did not want to speak up about error or sub-optimal prac-
tices, for fear of negative evaluation by colleagues, and/or being
‘‘shamed”. This meant that poor practices and errors were not
reported, gaps in the medication processes were not addressed
despite potential risks to patient safety. These issues were exacer-
bated by the related factors of lack of staff, over-burdened staff andsionals’ perceptions of medication errors in an adult oncology department
s://doi.org/10.1016/j.jsps.2018.10.001
W. Alharbi et al. / Saudi Pharmaceutical Journal xxx (2018) xxx–xxx 5trainees working without sufficient supervision/support
(Westbrook et al., 2011), as well as practical issues such as poor
handwriting and ‘‘look alike” medication names.
Although these latter issues were pertinent, and indeed may be
possible to address by systems changes, our impression from the
data was that the main barriers to achieving a positive patient
safety culture were attitudinal and behavioural. Our study revealed
that these healthcare professionals work in an environment where
they felt they will be punished if their mistakes were disclosed.
This supports previous findings that fear of consequences, lack of
legal support, and healthcare professionals’ perception that their
mistakes will be held against them are the main barriers for not
reporting errors (Cohen, 2000). This sets up a vicious circle where
patient safety events (e.g., errors, near misses) are not reported,
which means the department and individual cannot learn from
mistakes and avoid similar adverse events in the future
(Sarvadikar et al., 2010). Of course, it may be that our participants
lacked awareness of good practices, as has been found in other
studies (Ridelberg et al., 2014). However, the overwhelming mes-
sages from the data were that participants were aware that their
practice in relation to medication error and patient safety was less
than optimal, but cultural factors imposed certain behaviours and
ways of responding (Mobaraki and Söderfeldt, 2010) that did not
put patient safety at the forefront of clinical decision making or
response to error.
This study has strengths and limitations. In terms of limitations,
the study was conducted in one department and thus the findings
may not be transferrable to other settings (Guba and Lincoln,
1994). Importantly, however, this study was the first qualitative
study to explore the underlying reasons for medication errors in
an adult oncology department in Saudi Arabia. We used individual
interviews to ensure participant confidentiality, something we had
anticipated was of great importance given the findings from our
previous questionnaire survey in the same department (Alharbi
et al., 2018). We sampled a variety of healthcare professionals
directly involved in the delivery of care rather than focusing on
one professional group in isolation to reflect the multi-
disciplinary nature of care in oncology departments.
The findings of this study have a number of implications for
future research, policy and practice. In terms of further research,
this study revealed multiple different causes of medication errors
ranging from system-based gaps to behavioural and attitudinal
considerations. These need to be explored in greater detail in order
to plan, implement and evaluate any intervention in a complex
healthcare setting with multiple stakeholders (Craig et al., 2008).
For policy makers and leaders, improving the relationships and
expectations between the different healthcare professional groups
may be achieved through educational sessions, training courses,
and policy development and implementation, to promote coopera-
tion and collaboration among healthcare professionals (Salas and
Frush, 2012). In terms of staffing, the healthcare professionals to
patient ratio should be reconsidered to ensure the availability of
enough healthcare professionals and to reduce staff overload and
fatigue. New and junior staff should be subject to orientation pro-
grammes in order to familiarise them with the work routine and
patient safety related policies (Hartnell et al., 2012). As LASA med-
ications are a contributing factor for medication errors, policy mak-
ers should consider the development and implementation of LASA
policy to minimise healthcare professionals’ confusion and related
errors (Ostini et al., 2012). Departmental leadership should encour-
age a culture of transparency and non-punitive reporting of errors
to facilitate open disclosure of healthcare professionals’ concerns
and queries in order to promote organisational learning (Goh
et al., 2013; Sims et al., 2015). Moreover, there is a need to estab-
lish a clear and feasible process for feedback after reporting
adverse events evidence learning from adverse incidents andPlease cite this article in press as: Alharbi, W., et al. Exploring healthcare profes
in Saudi Arabia: A qualitative study. Saudi Pharmaceutical Journal (2018), httppromote reporting in this department (Armitage et al., 2010). It
is clear from other studies, albeit studies in other cultural contexts,
that a multidisciplinary approach, whereby different healthcare
professionals cooperatively develop and implement healthcare
plans (Atwal and Caldwell, 2006), can led to the provision of higher
quality and safer services (e.g. improved medication management
and reduction in medication errors) (Makowsky et al., 2009). This
may be a goal to work towards in the context of any intervention
to reduce medication errors.
In conclusion, there were numerous, intersecting human, cul-
tural and organizational factors contributing to medication errors
in adult oncology department. This qualitative study provides
insight into the reasons for the attitudes towards error and patient
safety identified in our earlier survey of the same department
(Alharbi et al., 2018). Our findings indicate that substantive
improvement in medication safety is likely to require multiple,
inter-relating, complex interventions aimed at changing attitudes
and behaviour rather than simple structural changes. More
research should be conducted to explore additional, context speci-
fic measures that may have the potential to improve medication
safety in this and similar departments.References
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